Pillstats
Rx only · Powder · Respiratory (Inhalation)

Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate

Brands: Trelegy Ellipta · Fluticasone Furoate + Umeclidinium Bromide + Vilanterol Trifenatate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD07AC17
RxCUI (US)41126
US makers1 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.21$6.42$9.63$12.84Jan 2026Jun 2026Jul 2026
$11.152
Latest avg · Jul 22, 2026
-0%
Since Jan 1, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

115K230K345K460K2025 Q12025 Q22025 Q32025 Q42026 Q1
345K
Rx · 2026 Q1
22.6M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
GlaxoSmithKline LLCunknown6SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMEDIDINIUM AND VILANTEROL INHALATION POWDER) 100-62.5-25MCG 60; NDC/UPC 0173-089…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • Mar 15, 2021
    RECALLRecall (Class II): Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg; 1 ELLIPT…

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC